Loredana Vesci

2.3k total citations
73 papers, 2.0k citations indexed

About

Loredana Vesci is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Loredana Vesci has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 30 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Loredana Vesci's work include Histone Deacetylase Inhibitors Research (14 papers), Cancer therapeutics and mechanisms (12 papers) and Peptidase Inhibition and Analysis (10 papers). Loredana Vesci is often cited by papers focused on Histone Deacetylase Inhibitors Research (14 papers), Cancer therapeutics and mechanisms (12 papers) and Peptidase Inhibition and Analysis (10 papers). Loredana Vesci collaborates with scholars based in Italy, Switzerland and Canada. Loredana Vesci's co-authors include Claudio Pisano, Giuseppe Giannini, Sergio Penco, Paolo Carminati, Massimo Castorina, Walter Cabri, Lucio Merlini, Sabrina Dallavalle, Gianfranco Battistuzzi and Valentina Zuco and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Loredana Vesci

73 papers receiving 1.9k citations

Peers

Countries citing papers authored by Loredana Vesci

Since Specialization

Citations

This map shows the geographic impact of Loredana Vesci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loredana Vesci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loredana Vesci more than expected).

Fields of papers citing papers by Loredana Vesci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loredana Vesci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loredana Vesci. The network helps show where Loredana Vesci may publish in the future.

Co-authorship network of co-authors of Loredana Vesci

This figure shows the co-authorship network connecting the top 25 collaborators of Loredana Vesci. A scholar is included among the top collaborators of Loredana Vesci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loredana Vesci. Loredana Vesci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The New Phytocomplex AL0042 Extracted from Red Orange By-Products Inhibits the Minimal Hepatic Encephalopathy in Mice Induced by Thioacetamide 2025 ·Biomedicines ·Loredana Vesci, Giulia Martinelli, Yongqiang Liu, (unknown), Mario Dell’Agli, (unknown), Sara Soldi, (unknown), Stefano Piazza, Enrico Sangiovanni, Francesco Meneguzzo	6
2	Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson’s disease 2023 ·npj Parkinson s Disease ·Jéssica Grigoletto, Fabiana Miraglia, Laura Benvenuti, Carolina Pellegrini, Sara Soldi, Serena Galletti, Antonino Cattaneo, Emilio Merlo Pich, Maria Grimaldi, Emanuela Colla, Loredana Vesci	8
3	Characterization of Early and Late Damage in a Mouse Model of Pelvic Radiation Disease 2023 ·International Journal of Molecular Sciences ·Roberta Vitali, Francesca Palone, Ilaria De Stefano, (unknown), Flavia Novelli, Emanuela Pasquali, Emiliano Fratini, Mirella Tanori, Simona Leonardi, Barbara Tanno, Eleonora Colantoni, Sara Soldi, Serena Galletti, Maria Grimaldi, A.G. Morganti, Lorenzo Fuccio, Simonetta Pazzaglia, Claudio Pioli, Mariateresa Mancuso, Loredana Vesci	2
4	Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation 2018 ·Chemical Science ·Elena Cini, (unknown), Elena Petricci, Maurizio Taddei, Laura Salvini, Giuseppe Giannini, Loredana Vesci, Ferdinando Maria Milazzo, Anna Maria Anastasi, Gianfranco Battistuzzi, Rita De Santis	22
5	Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo 2018 ·European Journal of Medicinal Chemistry ·Loredana Vesci, Ferdinando Maria Milazzo, Maria Antonietta Stasi, Silvia Pace, (unknown), (unknown), Elena Cini, Elena Petricci, Fabrizio Manetti, Rita De Santis, Giuseppe Giannini	15
6	Growth inhibition of human ovarian carcinoma by a novel AvidinOX-anchored biotinylated camptothecin derivative 2018 ·Bioorganic & Medicinal Chemistry Letters ·Olga Minenkova, Loredana Vesci, Rita De Santis, (unknown), Raffaella Cincinelli, Loana Musso, Sabrina Dallavalle, Giuseppe Giannini	2
7	7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors 2013 ·Bioorganic & Medicinal Chemistry ·Raffaella Cincinelli, Loana Musso, Lucio Merlini, Giuseppe Giannini, Loredana Vesci, Ferdinando Maria Milazzo, Nives Carenini, Paola Perego, Sergio Penco, Roberto Artali, Franco Zunino, Claudio Pisano, Sabrina Dallavalle	46
8	New retinoid derivatives as back-ups of Adarotene 2012 ·Bioorganic & Medicinal Chemistry ·Giuseppe Giannini, (unknown), Gianfranco Battistuzzi, Domenico Alloatti, (unknown), (unknown), Lucio Merlini, Sabrina Dallavalle, Raffaella Cincinelli, (unknown), Loredana Vesci, Federica Bucci, (unknown), Mario B. Guglielmi, Claudio Pisano, Walter Cabri	12
9	Camptothecins in tumor homing via an RGD sequence mimetic 2012 ·Bioorganic & Medicinal Chemistry Letters ·Domenico Alloatti, Giuseppe Giannini, Loredana Vesci, Massimo Castorina, Claudio Pisano, (unknown), Walter Cabri	13
10	Isoxazolo(aza)naphthoquinones: A new class of cytotoxic Hsp90 inhibitors 2012 ·European Journal of Medicinal Chemistry ·Alberto Bargiotti, Loana Musso, Sabrina Dallavalle, Lucio Merlini, Grazia Gallo, Andrea Ciacci, Giuseppe Giannini, Walter Cabri, Sergio Penco, Loredana Vesci, Massimo Castorina, Ferdinando Maria Milazzo, (unknown), Marcella Barbarino, Claudio Pisano, Chiara Giommarelli, Valentina Zuco, Michelandrea De Cesare, Franco Zunino	32
11	The atypical retinoid E-3-(3’-Adamantan-1-yl-4’-methoxybiphenyl-4-yl)-2-propenoic acid (ST1898) displays comedolytic activity in the rhino mouse model 2012 ·European Journal of Dermatology ·Teresa Odorisio, Naomi De Luca, Loredana Vesci, Pier Luigi Luisi, Pasquale Stano, Giovanna Zambruno, Claudio Pisano	3
12	Neurophysiological and neuropathological evaluation of the bortezomib effect in myeloma-bearing mice 2011 ·Journal of the Peripheral Nervous System ·C Ceresa, C Meregalli, M Bossi, Claudio Pisano, Loredana Vesci, (unknown), Guido Cavaletti	1
13	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl- l -Carnitine 2010 ·Clinical Cancer Research ·Claudio Pisano, Loredana Vesci, Ferdinando Maria Milazzo, Mario B. Guglielmi, (unknown), Marcella Barbarino, Maurizio D’Incalci, Massimo Zucchetti, Giovanna Petrangolini, Monica Tortoreto, Paola Perego, Valentina Zuco, Augusto Orlandi, Daniela Passeri, Paolo Carminati, (unknown), Franco Zunino	24
14	A Placental Growth Factor Variant Unable to Recognize Vascular Endothelial Growth Factor (VEGF) Receptor-1 Inhibits VEGF-Dependent Tumor Angiogenesis via Heterodimerization 2010 ·Cancer Research ·Valeria Tarallo, Loredana Vesci, (unknown), Maria Teresa Esposito, Teresa Riccioni, Lucio Pastore, Augusto Orlandi, Claudio Pisano, Sandro De Falco	49
15	The Identification of a Novel Natural Activator of p300 Histone Acetyltranferase Provides New Insights into the Modulation Mechanism of this Enzyme 2010 ·ChemBioChem ·Fabrizio Dal Piaz, Alessandra Tosco, Daniela Eletto, Anna Lisa Piccinelli, Ornella Moltedo, Silvia Franceschelli, Gianluca Sbardella, Paolo Remondelli, Luca Rastrelli, Loredana Vesci, Claudio Pisano, Nunziatina De Tommasi	59
16	Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Giuseppe Giannini, Mauro Marzi, (unknown), Gianfranco Battistuzzi, R Pezzi, (unknown), Walter Cabri, Loredana Vesci, Claudio Pisano	47
17	Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for In vitro and In vivo Activity 2005 ·Cancer Research ·Sabrina Basciani, Marina Brama, Stefania Mariani, Gabriele De Luca, Mario Arizzi, Loredana Vesci, Claudio Pisano, Susanna Dolci, Giovanni Spera, Lucio Gnessi	31
18	Acetyl-L-carnitine protects from peripheral neuropathy and reduces bone marrow injury in Taxol-treated mice 2000 ·Claudio Pisano, Loredana Vesci, (unknown), L Pacifici, (unknown), (unknown), (unknown), M. Cervoni, (unknown), Barbara Bucci, (unknown), (unknown), Paolo Carminati	1
19	Displacement of [3H]GABA binding to bovine brain receptors by sulfur-containing analogues 1990 ·Neurochemistry International ·Manoel Luís Costa, Loredana Vesci, Mario Fontana, (unknown), Silvestro Duprè, D. Cavallinì	6
20	Bovine brain ketimine reductase 1988 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Mirella Nardini, Giorgio Ricci, Loredana Vesci, Laura Pecci, D. Cavallinì	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact